← Evidence map

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2013

Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes.

Baptist GallwitzPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 23319869